US FDA approves Mirum Pharmaceuticals' drug for rare bone disorder
The FDA said the drug is approved to treat a rare bone disorder.
Sept 25 - The US Food and Drug Administration said on Friday it has approved Mirum Pharmaceuticals' drug for treatment of a rare bone disorder. Reporting by Kunal Das and Christy Santhosh in Bengaluru; Editing by Jonathan Ananda.